We collected information on 904 consecutive breast cancer patients treated with neoadjuvant chemotherapy at the European Institute of Oncology, Milan, Italy, between 1999 and 2011. The decrease of PgR and Ki-67 expression after preoperative chemotherapy has a prognostic role in breast cancer patients with residual disease.
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy / Montagna, E., Bagnardi, V., Viale, G., Rotmensz, N., Sporchia, A., Cancello, G., Balduzzi, A., Galimberti, V., Veronesi, P., Luini, A., Mastropasqua, M.G., Casadio, C., Sangalli, C., Goldhirsch, A., Colleoni, M.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 26:2(2015), pp. 307-313. [10.1093/annonc/mdu528]
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
Mastropasqua M. G.;
2015-01-01
Abstract
We collected information on 904 consecutive breast cancer patients treated with neoadjuvant chemotherapy at the European Institute of Oncology, Milan, Italy, between 1999 and 2011. The decrease of PgR and Ki-67 expression after preoperative chemotherapy has a prognostic role in breast cancer patients with residual disease.| File | Dimensione | Formato | |
|---|---|---|---|
|
Changes in PgR and Ki-67 in residual tumour.pdf
solo gestori archivio
Licenza:
Tutti i diritti riservati
Dimensione
273.19 kB
Formato
Adobe PDF
|
273.19 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
